Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 696
Selected: 0
NCT IDTitle
NCT00048776Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon
NCT01145313Impact of Atypical Antipsychotic Therapy on Health Outcomes and Costs Among Patients With Major Depressive Disorder
NCT05712746Samtasu Post-marketing General Drug Use-results Survey in Patients With Volume Overload in Heart Failure.
NCT00237913Schizophrenia Trial of Aripiprazole
NCT06799520A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)
NCT02847624Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD
NCT03737474A Long-Term Study of Brexpiprazole in Patients With Major Depressive Disorder
NCT03063944STAT Inhibitor OPB-111077, Decitabine and Venetoclax in Treating Patients With Acute Myeloid Leukemia That Is Refractory, Relapsed or Newly Diagnosed and Ineligible for Intensive Chemotherapy
NCT00292409A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices
NCT05542264A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia
NCT02012959Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hypervolemic Hyponatremia
NCT03240211Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL
NCT01959035Aripiprazole Once-monthly in Patients With Schizophrenia
NCT01439009Effect of Tolvaptan on Mid- to Long-term Prognosis of Heart Failure Patients
NCT00664014A Phase 2 Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia
NCT03179787Post-Marketing Surveillance Study of Aripiprazole in Patients With Autism
NCT04182958A Phase I, Open-Label Trial to Assess the Absorption, Metabolism, and Excretion of (14C)-OPC-61815 in Healthy Male Japanese Subjects
NCT01972711Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype Characteristics
NCT02472652Aripiprazole, Abilify Maintena Collaborative Clinical Protocol
NCT01129882An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With Schizophrenia
NCT01837797Efficacy and Safety of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
NCT01122927Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
NCT00731549Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
NCT00361790Aripiprazole and Lexapro Drug Interaction Study
NCT00234078Dose-response Study of OPC-12759 Ophthalmic Suspension
NCT00796562Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy
NCT01955161Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
NCT03724942Brexpiprazole for the Long-term Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type
NCT00525265A Clinical Pharmacological Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)
NCT01922258Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
NCT00261443A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania
NCT03376763MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics
NCT00237939A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices
NCT05190744Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration
NCT01995370Cilostazol Stroke Prevention Study for Antiplatelet Combination
NCT05248659Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)
NCT05628103A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medication
NCT02050854Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia
NCT00329810Effect on Cognitive Function of a Treatment With Aripiprazole
NCT03872596Trial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolar Disorder
NCT00940173Open-label Investigation of the Safety and Effectiveness of DIABECELL(R) in Patients With Type I Diabetes Mellitus
NCT00097266Study of Aripiprazole in Patients With Acute Bipolar Mania
NCT01727700Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
NCT00484471ABLE: Abilify in Bipolar Disorder for Long-term Effectiveness
NCT07314333A Trial to Assess How Centanafadine Interacts With Stimulants in the Body
NCT01141387Outcomes in MEasurement-Based Treatment
NCT02219009Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole
NCT00823849Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker
NCT02223715Prospective Observational Study of Clostridium Difficile Infection in Asian Pacific Countries
NCT03287869A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder.